Twelve additional mpox vaccination sites are now open across England. There were previously 19 sites, located in just three regions, London, Manchester and Brighton. But additional sites have ...

Twelve additional mpox vaccination sites are now open across England. There were previously 19 sites, located in just three regions, London, Manchester and Brighton. But additional sites have since ...

Clinical trials planned to begin patient enrollment during 2025 to evaluate Gylden’s T cell Priming (TcP) candidates against Dengue (Phase II) ...

First chikungunya vaccine approved in Europe for persons as young as 12 years old.On track for launch in key European markets in the first half of 2025. COPENHAGEN, Denmark, February 28, 2025 ...

COPENHAGEN, Denmark, February 28, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced that the European Commission has granted marketing authorization in Europe for VIMKUNYA® for active ...

CDC data’s “explicit purpose” is to guide researchers toward the places and people who most need attention, Patrick Sullivan, ...

Contract manufacturing agreement marks the first step in collaboration to establish supply for expanded access to chikungunya vaccines in low- and middle-income countries. COPENHAGEN, Denmark ...

Figure 10 displays the heatmaps generated by Grad-CAM for each model in Mpox classification. Figure 10 Comparison of heat maps generated by Grad-CAM for each model. Through the heatmaps, we can ...

The case counts seem to be dropping. But health officials say that's because violence in the Democratic Republic of Congo ...

A new mpox variant, clade 1b, is spreading rapidly in the DRC, with increased human-to-human transmission and risks for ...

Kaseya is director general of the Africa Centers for Disease Control and Prevention. He's talking about mpox, a virus that causes painful blisters and can be fatal. For much of the world ...